BioCentury
ARTICLE | Emerging Company Profile

Jaguar to deploy $139M series B toward broad gene therapy pipeline

Emerging Company Profile: Jaguar, founded by AveXis vets, raises $139M series B led by Lilly, Deerfield

April 14, 2021 1:42 AM UTC

Less than two months after emerging from stealth, Jaguar raised a $139 million series B co-led by Lilly and Deerfield that will further facilitate translation of its executives’ experience developing SMA gene therapy Zolgensma into gene therapies for broader indications.

Arch Venture Partners, Goldman Sachs and Nolan Capital also participated in the financing, which Jaguar Gene Therapy LLC will use to advance its initial preclinical programs for galactosemia, autism and Type I diabetes...

BCIQ Company Profiles

Jaguar Gene Therapy LLC